First-in-Human Cardiac and Whole-Body 124I-evuzamitide (AT-01) PET/MRI in Systemic Amyloidosis
September 30, 2023
AUTHORS:
Ahmad Masri, Derrick Gillan, Jessica Cardin, Jad Chehab, Adam Brown, Eva Medvedova, Nadine Mallak
Amyloidosis Center, Knight Cardiovascular and Cancer Institutes, and Molecular Imaging and Therapy Section, Oregon Health & Science University, Portland, OR
